Tempest Therapeutics Inc. (TPST)
NASDAQ: TPST
· Real-Time Price · USD
10.58
1.10 (11.60%)
At close: Aug 15, 2025, 3:59 PM
10.72
1.32%
After-hours: Aug 15, 2025, 07:28 PM EDT
Tempest Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.87M | -10.86M | -13.81M | -10.56M | -9.57M | -7.9M | -7.49M | -6.79M | -7.58M | -7.64M | -9.1M | -8.95M | -9.17M | -8.49M | -7.78M | -8.11M | -7.06M | -5.36M |
Depreciation & Amortization | 67K | 68K | 49K | 97K | 155K | 88K | 85K | 88K | 83K | 125K | 217K | 201K | 112K | 108K | 102K | 107K | 87K | 78K |
Stock-Based Compensation | 1.09M | 1.39M | 1.33M | 1.33M | 1.32M | 1.32M | 1.1M | 563K | 440K | 446K | 428K | 438K | 367K | 328K | 278K | 296K | 411K | 120K |
Other Working Capital | -4.56M | 1.33M | 1.22M | -1.7M | 1.87M | -1.38M | -52K | -1.09M | 461K | -1.74M | 1.44M | -513K | -956K | 896K | 379K | -312K | 507K | -978K |
Other Non-Cash Items | 312K | 303K | 309K | 305K | 410K | 487K | 2.03M | 468K | 457K | 485K | 449K | 276K | 470K | 375K | 374K | 545K | 421K | 139K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.03M | 1.06M | 1.98M | -1.36M | 2.17M | -1.18M | -343K | -820K | 209K | -1.72M | 1.53M | -1.04M | -195K | 573K | -960K | -4.63M | 6.27M | -1.29M |
Operating Cash Flow | -8.43M | -8.04M | -10.15M | -10.18M | -5.51M | -7.19M | -6.17M | -6.49M | -6.39M | -8.3M | -6.48M | -9.07M | -8.41M | -7.11M | -7.99M | -11.79M | 127K | -6.31M |
Capital Expenditures | n/a | n/a | -3K | -15K | -249K | -168K | -7K | n/a | -117K | -46K | -356K | -108K | -95K | -3K | -27K | -24K | -70K | -14K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38K | n/a | n/a |
Investing Cash Flow | n/a | n/a | -3K | -15K | -249K | -168K | -7K | n/a | -117K | -46K | -356K | -108K | -95K | -3K | -27K | 14K | -70K | -14K |
Debt Repayment | -4.23M | -2.2M | -2.2M | -2.2M | n/a | n/a | n/a | n/a | n/a | n/a | -4.74M | n/a | n/a | n/a | n/a | n/a | n/a | 15M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 111K | n/a | 197K | n/a | n/a | n/a | n/a | n/a | n/a | 7.28M | n/a | 40K | -297K | 10.95M | -56K |
Financial Cash Flow | 1.2M | -721K | 17.95M | 1.54M | 4.56M | 450K | 34.35M | 21K | 1.19M | 44K | -4.73M | 350K | 14.38M | 1.4M | -9K | 3.17M | 40.96M | 14.94M |
Net Cash Flow | -7.23M | -8.76M | 7.8M | -9.01M | -1.2M | -6.9M | 28.11M | -6.47M | -5.32M | -8.3M | -11.56M | -8.83M | 5.87M | -5.71M | -7.93M | -8.7M | 41.02M | 8.62M |
Free Cash Flow | 8.04M | -8.04M | -10.15M | -10.2M | -5.76M | -7.35M | -6.18M | -6.49M | -6.51M | -8.35M | -6.83M | -9.18M | -8.51M | -7.11M | -8.01M | -11.81M | 57K | -6.32M |